Concepts for treatment of micrometastases developed in murine systems.

Concepts for treatment of micrometastases developed in murine systems. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Concepts for treatment of micrometastases developed in murine systems. Abstract Text:

F M Schabel,

Small tumor cell foci, whether left in situ during primary surgical excision or escaping lethal radiation damage, as well as distant metastases, are the primary reason for treatment failure in man and are the proper targets for the chemotherapist and immunotherapist. Since cure probably requires reduction of the total body burden of tumor cells to very small numbers (possibly to less than one cell), and since first-order kinetics of tumor cell kill by drugs appears to be a natural law in cancer chemotherapy, drug treatment should be started as soon as possible after likely noncurative primary treatment with surgery or radiation. Current knowledge of tumor cell population growth kinetics indicates that the growth fraction (viable tumor cells undergoing active cell replication) is inversely related to population size. Tumor cells in micrometastases should, therefore, be more sensitive to anticancer drugs active against anabolizing cells than are tumor cells in the larger, grossly apparent primary tumor from which they were derived. This indicates the probability that micrometastases will be effectively responsive to more drugs than is the primary and clinically apparent tumor from which they came. Studies with at least four metastatic and uniformly fatal murine solid tumors (lung, breast, colon, and melanoma) have demonstrated significantly improved cure rates with drug treatment following surgical removal of the grossly apparent primary tumor than can be obtained with either surgery or drug treatment when used alone. Further, both disease staging and drug dosage have been shown to influence cure rates of combined-modality treatment. With several mouse tumors, a significantly smaller number of viable tumor cells can establish lethal tumors in the presence of radiation-inactivated tumor cells than in their absence. This suggests that small numbers of residual viable tumor cells in radiation-treated tumor sites may be a greater threat to clinical cure than smaller tumor cell populations remaining in situ after surgery.

Concepts for treatment of micrometastases developed in murine systems. Publishing Authors By Initials

FM Schabel,

For similar organic chemicals: nitroso compounds: nitrosourea compounds: lomustine: semustine research abstracts see: organic chemicals: nitroso compounds: nitrosourea compounds: lomustine: semustine research

PUBMED ID PMID:

MEDLINE DATE:

Concepts for treatment of micrometastases developed in murine systems. Journal Published:

PUBLICATION TYPE: Review

Journal: AJR. American journal of roentgenology

VOLUME: 126

Page Numbers: 500-11

Journal Abbreviation:

ISSN: 0361-803X

DAY: 15

MONTH: Mar

YEAR: 1976

Concepts for treatment of micrometastases developed in murine systems. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7708173

Concepts for treatment of micrometastases developed in murine systems. Keywords Mesh Terms:

KEYWORDS: Semustine

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Concepts for treatment of micrometastases developed in murine systems. Information

Substance Name: Cyclophosphamide

Registry Number: 50-18-0

Grant and Affiliation Information for Concepts for treatment of micrometastases developed in murine systems.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: AJR Am J Roentgenol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Concepts for treatment of micrometastases developed in murine systems Related Publications

• "Compression paddle gallstone": artifact of standard radiographic accessory.
• Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878).
• Antiviral chemotherapy as an indicated adjunct to cancer chemotherapy.
• CT evaluation of thickened esophageal walls.
• Concepts for treatment of micrometastases developed in murine systems.
• Development of Friend leukemia virus in spleen and plasma of Swiss mice.
• Ectopic cranium: postoperative abdominal wall skull fragments.
• Effect of 1,3-bis(2-chlorethyl)-1-nitrosourea (NSC-409962) and nitrogen mustard (NSC-762) on kinetic behavior of cultured L1210 leukemic cells.
• Experimental evaluation of potential anticancer agents. VII. Cross resistance of alkylating agent-resistant neoplasms.
• Experimental evaluation of potential anticancer agents. XI. Quantitative response of the Sa180 system to deoxypyridoxine.
• Experimental evaluation of purine antagonists as anticancer agents.
• Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
• Growth requirements and biologic characteristics of leukemia L1210 cells in culture.
• Historical development and future promise of the nitrosoureas as anticancer agents.
• Laboratory study of the epidemiology of poliomyelitis.
• Rationale for perioperative anticancer treatment.
• Recovery of poliomyelitis virus from the throat during the incubation period.
• Screening, the cornerstone of chemotherapy.
• Some observations on the carcinostatic activity of Eponate on Fortner hamster plasmacytoma.
• Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas.
• Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
• The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis.